Skip to main content

Clinical Trials on Trial: Lawsuits Stemming from Clinical Research

  • Living reference work entry
  • First Online:
Principles and Practice of Clinical Trials
  • 487 Accesses

Abstract

Clinical trials and the law routinely intersect, and as a result, litigation occasionally arises out of clinical trial activities. Such litigation includes not only personal injury suits – claims by individuals who allege they suffered injury during a clinical trial – but also breach-of-contract lawsuits, intellectual property matters, and even criminal prosecutions. This chapter provides an overview of the types of litigation that might arise out of clinical trials. The chapter focuses on personal injury litigation and, in particular, the related duties that courts have held apply to participants in clinical trials, including sponsors, investigators, and institutional review boards. Notwithstanding this focus, the chapter also provides an overview of lawsuits grounded in other areas of the law. The ultimate goal is to provide researchers with a basic understanding of litigation-related issues, in the hopes that such knowledge might aid them in avoiding pitfalls that increase litigation risk.

The authors represent pharmaceutical and medical device companies in various litigation matters. Any opinions expressed are those of the authors and do not necessarily reflect the views of their firm. This book chapter is for general information purposes and is not intended to be, nor should it be taken as, legal advice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

Cases

  • Abney v. Amgen, Inc., 443 F.3d 540 (6th Cir. 2006)

    Google Scholar 

  • BeRousse v. Janssen Research & Development, LLC, 2017 WL 4255075 (S.D. Ill. Sept. 26, 2017)

    Google Scholar 

  • Bristol-Myers Squibb Co. v. Superior Court of California, 137 S. Ct. 1773 (2017)

    Google Scholar 

  • Brown v. Philadelphia College of Osteopathic Medicine, 760 A.2d 863 (Pa. Super. Ct. 2000)

    Google Scholar 

  • Cacchillo v. Insmed Inc., 833 F. Supp. 2d 218 (N.D.N.Y. 2011)

    Google Scholar 

  • Cacchillo v. Insmed Inc., 2013 WL 622220 (N.D.N.Y. Feb. 19, 2013)

    Google Scholar 

  • Connelly v. Iolab Corp., 1995 WL 250794 (Mo. Ct. App. May 2, 1995)

    Google Scholar 

  • CTI Clinical Trial Services, Inc. v. Gilead Sciences, Inc., 2013 WL 1641348 (S.D. Ohio Apr. 16, 2013)

    Google Scholar 

  • Darke v. Estate of Isner, 20 Mass. L. Rptr. 419, 2005 WL 3729113 (Mass. Super. Ct. Nov. 22, 2005)

    Google Scholar 

  • Dubose v. Bristol-Myers Squibb Co., 2017 WL 2775034 (N.D. Cal. June 27, 2017)

    Google Scholar 

  • Dyson v. Bayer Corp., 2018 WL 534375 (E.D. Mo. Jan. 24, 2018)

    Google Scholar 

  • Eli Lilly and Co. v. Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369 (Fed. Cir. 2006)

    Google Scholar 

  • Friter v. Iolab Corp., 607 A.2d 1111 (Pa. Super. Ct. 1992)

    Google Scholar 

  • Gaston v. Hunter, 588 P.2d 326 (Ariz. Ct. App. 1978)

    Google Scholar 

  • Heinrich v. Sweet, 308 F.3d 48 (1st Cir. 2002)

    Google Scholar 

  • In re: Immune Response Securities Litigation, 375 F. Supp. 2d 983 (S.D. Cal. 2005)

    Google Scholar 

  • In re: Incyte Shareholder Litigation, 2014 WL 707207 (D. Del. Feb. 21, 2014)

    Google Scholar 

  • In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability Litigation, 892 F.3d 624 (4th Cir. 2018)

    Google Scholar 

  • In re: Xarelto Cases, 2018 WL 809633 (Cal. Super. Ct. Feb. 6, 2018)

    Google Scholar 

  • Kernke v. The Menninger Clinic, Inc., 173 F. Supp. 2d 1117 (D. Kan. 2001)

    Google Scholar 

  • Kershaw v. Reichert, 445 N.W.2d 16 (N.D. 1989)

    Google Scholar 

  • Kus v. Sherman Hospital, 644 N.E.2d 1214 (Ill. App. Ct. 1995)

    Google Scholar 

  • Liu v. Janssen Research & Development, 2018 WL 272219 (Cal. Ct. App. Jan. 3, 2018)

    Google Scholar 

  • Looney v. Moore, 886 F.3d 1058 (11th Cir. 2018)

    Google Scholar 

  • Merck KGaA v. Integra Lifesciences I, Ltd., 545 U.S. 193 (2005)

    Google Scholar 

  • Milton v. Robinson, 27 A.3d 480 (Conn. App. Ct. 2011)

    Google Scholar 

  • Moss v. Wyeth Inc., 872 F. Supp. 2d 162 (D. Conn. 2012)

    Google Scholar 

  • Murthy v. Abbott Laboratories, 847 F. Supp. 2d 958 (S.D. Tex. 2012)

    Google Scholar 

  • Perez v. Progenics Pharmaceuticals, Inc., 965 F. Supp. 2d 353 (S.D.N.Y. 2013)

    Google Scholar 

  • Sanofi v. Glenmark Pharmaceuticals Inc., USA, 204 F. Supp. 3d 665 (D. Del. 2016)

    Google Scholar 

  • Spedale v. Constellation Pharmaceuticals Inc., 2019 WL 3858901 (D. Ariz. Aug. 16, 2019)

    Google Scholar 

  • Sykes v. U.S., 507 F. App’x 455 (6th Cir. 2012)

    Google Scholar 

  • Telectronics Pacing Systems, Inc. v. Ventritex, Inc., 982 F.2d 1520 (Fed. Cir. 1992)

    Google Scholar 

  • Tracy v. Merrell Dow Pharmaceuticals, 569 N.E.2d 875 (Ohio 1991)

    Google Scholar 

  • Wawrzynek v. Statprobe, Inc., 2007 WL 3146792 (E.D. Pa. Oct. 25, 2007)

    Google Scholar 

  • Wholey v. Amgen, Inc., 165 A.D.3d 458 (N.Y. App. Div. 2018)

    Google Scholar 

  • Zeman v. Williams, 2014 WL 3058298 (D. Mass. July 7, 2014)

    Google Scholar 

Statutes and Regulations

Secondary Sources

  • Agati A (2006) Clinical research trials in the courtroom. In: Clinical research law and compliance handbook. Jones & Bartlett Publishers, Sudbury

    Google Scholar 

  • Bal S (2009) An introduction to medical malpractice in the United States. Clin Orthop Relat Res 467:339–347

    Article  Google Scholar 

  • Chiacchio T (2017) Avoiding drug development clinical trials from being an invalidating public use. IPWatchdog.com, November 9, 2017. https://www.ipwatchdog.com/2017/11/09/drug-development-clinical-trials-invalidating-public-use/id=89799/

  • ElBoghdady D (2014) SAC’s Martoma found guilty of insider trading. Washington Post, February 6, 2014

    Google Scholar 

  • McAllister D (2007) Are clinical trial sponsors the next target for false claims act enforcement. J Clin Res Best Pract 3(10):1–10

    Google Scholar 

  • Morreim E (2004) Litigation in clinical research: malpractice doctrines versus research realities. J Law Med Ethics 32:474–484

    Article  Google Scholar 

  • Morreim E (2005) Clinical trials litigation: practical realities as seen from the trenches. Account Res 12:47–67

    Article  Google Scholar 

  • Russo A, Johnson J (2015) Research use exemptions to patent infringement for drug discovery and development in the United States. Cold Spring Harb Perspect Med 5:1–10

    Article  Google Scholar 

  • Tereskerz P (2010) Data safety monitoring boards: legal and ethical considerations for research accountability. Account Res 17:30–50

    Article  Google Scholar 

  • Tereskerz P (2012) Clinical research and the law. Wiley-Blackwell, London

    Book  Google Scholar 

  • Valdes S, McGuire P (2004) Contract Research Organizations (CROs) may be the next trend in clinical trials liability. J Biolaw Bus 7:11–15

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John J. DeBoy .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

DeBoy, J.J., Wang, A.X. (2020). Clinical Trials on Trial: Lawsuits Stemming from Clinical Research. In: Piantadosi, S., Meinert, C. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_164-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52677-5_164-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52677-5

  • Online ISBN: 978-3-319-52677-5

  • eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering

Publish with us

Policies and ethics